Prostate cancer: symptoms, PSA test, treatment and survival

The prostate sits just below the bladder and surrounds part of the urethra — the tube that carries urine. Its job is to make fluid that forms part of semen. Cancer develops when cells in the gland grow out of control.

Most prostate cancers are adenocarcinomas, meaning they start in the glandular cells. Some stay inside the prostate for years and may never cause harm. Others break through the capsule, reach nearby lymph nodes, or spread to bones and other organs.

Cancer Research UK counts around 57,900 new diagnoses a year in the UK (2019 and 2021–2022 average, about 160 a day). Prostate Cancer UK, using more recent figures published in January 2026, says more than 64,000 men are now diagnosed every year. Around 12,300 men die of prostate cancer each year. About one in eight UK men will be diagnosed in their lifetime.

The prostate surrounds the urethra, so a growth large enough to press on that tube can change how you pee. Those same changes are far more often caused by a non-cancerous enlarged prostate (benign prostatic hyperplasia, or BPH) or by prostatitis (inflammation). That is why symptoms are a reason to see a GP, not a diagnosis on their own.

Because early, treatable disease is often silent, the PSA blood test is the main way to find prostate cancer before symptoms start. Do not wait for pain or blood if you are in a higher-risk group — ask about a PSA test.

You do not need to have every symptom on a list. One persistent change is enough to book an appointment. Take a note of how long it has been going on, whether it is worse at night, and whether anyone in your family has had prostate, breast or ovarian cancer — that helps the GP.

World Aid Network publishes this as general information, not a diagnosis. Only a clinician can assess you. This guide does not fund or replace NHS care in the UK.

There is no national NHS prostate cancer screening programme like breast or bowel screening. Instead, the NHS Prostate Cancer Risk Management Programme lets men aged 50 and over request a PSA test after an informed discussion about the benefits and the limits.

A raised PSA usually leads to an MRI scan of the prostate, then a targeted biopsy if the scan looks suspicious. The biopsy is what confirms cancer. PSA alone cannot do that.

To avoid a falsely high reading, GPs often advise not ejaculating or doing vigorous exercise such as cycling in the 48 hours before the test, and waiting if you have a urine infection.

Screening for everyone has not been introduced because PSA is not accurate enough on its own. It misses some cancers, raises false alarms in men who do not have cancer, and can find slow-growing tumours that would never have caused harm — leading to treatment some men did not need.

Informed choice is the current UK approach: you can have the test if you want it, once you understand those trade-offs. If you have symptoms, that is investigation, not screening — see a GP either way.

You cannot change your age, ethnicity or family history. What you can change is whether you have the conversation about a PSA test at the right age, and whether urinary or bone-pain symptoms are checked rather than put down to 'getting older'.

Diet evidence is weaker. The NHS does not recommend a special prostate diet beyond general healthy eating, a healthy weight and staying active. Those steps help overall health even when they do not specifically prevent prostate cancer.

The dedicated prostate cancer in Black men guide owns 1 in 4 lifetime risk, PSA from 45 for Black African and Black Caribbean men, and a donate form. This hub page owns general symptoms, Gleason score, stages and UK survival.

Almost 1,600 Black men are diagnosed with prostate cancer each year in England. If you are Black, you do not need symptoms to ask. Book a GP appointment from age 45, say you want to discuss a PSA test, and mention any family history. Our 30-second risk checker can help you see where you sit before that appointment.

MRI before biopsy has changed UK practice: many men with a reassuring scan never need a biopsy. When a biopsy is needed it is usually MRI-targeted, which is more accurate than older random sampling.

Together, PSA level, Gleason grade (or ISUP grade group) and TNM stage put the cancer into a risk category. That category — not any single number — guides whether active surveillance, surgery, radiotherapy or hormone therapy is discussed first.

Gleason 6 (grade group 1) cancers are often slow-growing and may be suitable for active surveillance. Gleason 8 to 10 (grade groups 4 and 5) cancers are more likely to grow and spread, so treatment is usually recommended if the man is fit enough.

The score is only one part of the picture. Stage, PSA, MRI findings and your general health all matter. Ask your specialist to explain your grade group in plain English before you decide on treatment.

Localised (Stage I–II) disease is often curable with surgery or radiotherapy, and some low-risk cases are monitored instead. Locally advanced (Stage III) disease is still frequently treated with the aim of long-term control. Metastatic (Stage IV) disease is not usually curable, but hormone therapy and other drugs can control it for years.

In England in 2022, 53% of prostate cancers with a known stage were found at Stage I or II (Cancer Research UK). Finding cancer while it is still inside the prostate is why the PSA conversation matters.

Because the prostate sits next to nerves and muscles used for erections and bladder control, surgery and radiotherapy can cause urinary leaks and erection difficulties. Techniques have improved, including nerve-sparing and robotic surgery, but no treatment is side-effect free. Hormone therapy commonly causes hot flushes, fatigue, loss of libido and thinner bones.

For many men with low-risk disease, the kindest first step is not to treat at all, but to watch closely. That is active surveillance — a recognised NHS approach, not a delay.

Watchful waiting is different: it is a gentler approach, usually for older men or men with other serious illnesses, focused on treating symptoms if they appear rather than trying to cure the cancer.

If you are offered active surveillance, ask how often you will have PSA tests and MRI scans, and what change would trigger treatment. It is a plan, not 'doing nothing'.

Cancer Research UK reports around 57,900 new cases a year and around 12,300 deaths a year. Prostate Cancer UK says more than 540,000 men in the UK are living with or after prostate cancer. Most men diagnosed in the UK die with the disease rather than from it.

These figures describe groups, not individuals. Your outlook depends on stage, grade, how far it has spread, other illnesses, and which treatments you can have.

Cure is not the only good outcome. For some slow-growing cancers, living well without treatment side effects is the aim. For advanced disease, the aim is control: fewer symptoms, longer life, and support for urinary, sexual and bone health.

If you are comparing charities, remember that research charities fund trials and discovery. World Aid Network funds treatment costs for poor patients overseas who have already been recommended care they cannot pay for.

In the UK, most men diagnosed early can expect to live many years. In a low-income setting a man may present late, with bone pain, because there was no PSA test and no money for an MRI or biopsy. Hormone therapy, radiotherapy and surgery then sit behind a hospital bill his family cannot meet.

World Aid Network does not run UK clinics and does not replace the NHS. We pay treatment costs through locally licensed oncologists in registered partner hospitals in Pakistan, Indonesia and Malaysia — never as cash to patients. The Cancer Emergency Appeal funds all types of cancer, including prostate cancer.

This is treatment access, not laboratory research and not UK NHS care. Clinicians in partner hospitals decide the medical plan. We fund the bill.

Give what you can on this page or via the Cancer Emergency Appeal. A monthly gift helps partners keep treating the next man who is turned away.

Use the form beside this guide, or open the donate page and select cancer care. If you are collecting at a workplace, mosque, church or in someone's memory, email [email protected] and we will mark the gift.

If you need UK support as a patient or relative, contact your GP, NHS 111, Prostate Cancer UK or Macmillan. We are an overseas treatment-funding charity, not a UK helpline.